Milestones :: Perspectives :: Research
Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
European Medicines Agency
News & Press Releases
News: COVID-19 vaccine Spikevax approved for children aged 12 to 17 in EU (new)
CHMP, Last updated: 23/07/2021
EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax (previously COVID-19 Vaccine Moderna) to include use in children aged 12 to 17 years. The vaccine is already authorised for use in people aged 18 and above…
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2021 (new)
CHMP, Last updated: 23/07/2021
News: COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect (new)
PRAC, Last updated: 22/07/2021
News: EMA starts rolling review of COVID-19 vaccine Vidprevtyn (new)
CHMP, Last updated: 20/07/2021
EMA’s human medicines committee (CHMP) has started a rolling review of Vidprevtyn, a COVID-19 vaccine developed by Sanofi Pasteur.
::::::
European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
News
SARS-COV-2 Delta variant now dominant in much of the European Region and efforts must be reinforced to prevent transmission, warn WHO/Europe and ECDC
Press release – 23 Jul 2021
Publication
Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence
Technical report – 22 Jul 2021
::::::


Data as of 2021-07-24
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
::::::
European Commission
https://ec.europa.eu/commission/presscorner/home/en
Press release 23 July 2021
Application of EU Law in 2020: Protecting our agreed rules and shared values during a pandemic
Press release 22 July 2021
Vaccinating the world: ‘Team Europe’ to share more than 200 million doses of COVID-19 vaccines with low and middle-income countries by the end of 2021
Ensuring access to safe and affordable COVID-19 vaccines around the world, and notably for low and middle-income countries, is a priority for the European Union.
Press release 22 July 2021
Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants
The Commission has short-listed 11 new projects worth €120 million from Horizon Europe, the biggest European research and innovation programme (2021-2027), for supporting and enabling urgent research into the coronavirus and its variants.
::::::
Africa: COVID-19 – Announcements/Regulatory Actions/Deployment
Current at 21 Jul 2021; Full scale, interactive dashboard available at: https://africacdc.org/covid-19-vaccination/

::::::
Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
07.21.2021
NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac,” a Cape Town-based, South African biopharmaceutical company, to manufacture the Pfizer-BioNTech COVID-19 Vaccine for distribution within the African Union.
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network, which will now span three continents and include more than 20 manufacturing facilities. To facilitate Biovac’s involvement in the process, technical transfer, on-site development and equipment installation activities will begin immediately.
Pfizer and BioNTech expect that Biovac’s Cape Town facility will be incorporated into the vaccine supply chain by the end of 2021. Biovac will obtain drug substance from facilities in Europe, and manufacturing of finished doses will commence in 2022. At full operational capacity, the annual production will exceed 100 million finished doses annually. All doses will exclusively be distributed within the 55 member states that make up the African Union…